Stonepine Capital Management, LLC Ani Pharmaceuticals Inc Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$23.09 - $33.46 $63,266 - $91,680
2,740 Added 10.51%
28,800 $854,000
Q1 2022

May 16, 2022
SELL
$26.91 - $47.15 $705,849 - $1.24 Million
-26,230 Reduced 50.16%
26,060 $733,000
Q4 2021

Feb 14, 2022
BUY
$32.97 - $56.85 $1.72 Million - $2.97 Million
52,290 New
52,290 $2.41 Million

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
18.8M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email